MedOnect
A Breakthrough in Blood Cancer Treatment

As per scientific studies, cellular regeneration in the human body is based on the energy derived from food, water, and the level of pH in the environment. However, the team at MedOncet Therapeutics, Inc., a provider of technology-based treatments to defy cancer, improve conventional scientific solutions to opioids, and combat infectious diseases, discovered that cells are like batteries that can depend on electric charges to survive. As MedOncet delved deeper into these aspects of cellular function, it found that the cells have specific electrical charges that aid in cell regeneration. This gave them a renewed scientific understanding of cancerous cells and their spread in the body. After intense research, the company brought to light an innovative therapy for blood cancer patients.

The MedOncet team observed that when a cell has a tumor, it becomes weak in electrical charges before its death. Noticing this behavior in cancerous cells, the company made a breakthrough invention by reversing the process of a tumor-killing a healthy cell. MedOncet’s therapeutic approach focuses on nurturing the cell by delivering electric charges into the tumor cell, weakening it, and stopping the spread until healthy cells regenerate.

To implement this treatment among patients, the company created the MedOnect Life Treatment Vest with electronic ultrasound boards and five main parts that work together to generate specific frequencies of up to 27.12 MHz.

The transmission happens through a device that receives and broadcasts electric signals into the body through a medical-grade cotton vest. The frequency then penetrates the lymph nodes through electrodes placed under the patient’s armpit. The electrical pulses help repair defiant cells and allow enzymes to function properly, ensuring the cell’s vitality.

“Our job is not to compete but to complete the process of cancer therapy by enabling patients to avail treatment at their homes,” says Dr. Ziad George, Executive Manager of MedOncet.

In partnership with healthcare facilities, MedOncet provides its product to oncologists and helps patients undergo treatment in the comfort of their homes. The vest establishes a simultaneous connection between the patient, the oncologist, and the hub to monitor the patient effectively. To prevent the further spread of the tumor, MedOncet conducts this treatment for patients under the supervision of oncologists. While the vest monitors every change in the patient and cancer growth, the oncologists ensure targeted treatment.

Presently, MedOncet is continuing the clinical trial of its product and aims to start production soon. The company is motivated to further widen its scope from blood cancer to other forms of the disease. In this regard, the company is looking forward to collaborating with healthcare institutions, hospitals, and clinicians and providing them with its service. The company’s line of products and services align with the formula of creating sustainable cells that grow to be healthy, growing elements in the body. MedOncet’s endeavor to provide more solutions in immunotherapy and reduce the severity of the cancer is like a light at the end of a tunnel for patients around the world.